SUMMARY Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid were measured in cerebrospinal fluid, taken during pneumoencephalography, from a large series of patients, the majority of whom were epileptics, most of them receiving anticonvulsants. CSF indoleacetic acid reflects CNS tryptamine metabolism in the same way that CSF 5-hydroxyindoleacetic acid reflects CNS 5-hydroxytryptamine metabolism. Our data suggest that (i) the brain tryptophan content is an important factor in the control of both 5-hydroxytryptamine and tryptamine synthesis (ii) brain 5-hydroxytryptamine metabolism exhibits a U-shaped relationship with age (iii) the mean brain tryptophan content and rate of 5-hydroxytryptamine metabolism are greater for women than men (iv) indoleamine metabolism is unaffected in untreated epileptics compared with non-epileptics, but anticonvulsant drugs decrease the rate of 5-hydroxytryptamine metabolism.Measurement of amine related compounds in the cerebrospinal fluid (CSF) is the most commonly used method for studying biogenic amine metabolism in the human CNS. For the indoleamines, the concentration of tryptophan in the CSF is a reasonably good index of the CNS tryptophan content,1 while the concentration of 5-hydroxyindoleacetic acid (5HIAA) in the CSF reflects CNS 5-hydroxytryptamine (5HT)